468 related articles for article (PubMed ID: 29317252)
1. Flavonoids and the gastrointestinal tract: Local and systemic effects.
Oteiza PI; Fraga CG; Mills DA; Taft DH
Mol Aspects Med; 2018 Jun; 61():41-49. PubMed ID: 29317252
[TBL] [Abstract][Full Text] [Related]
2. Anthocyanin actions at the gastrointestinal tract: Relevance to their health benefits.
Oteiza PI; Cremonini E; Fraga CG
Mol Aspects Med; 2023 Feb; 89():101156. PubMed ID: 36379746
[TBL] [Abstract][Full Text] [Related]
3. Citrus flavonoids and the intestinal barrier: Interactions and effects.
Wang M; Zhao H; Wen X; Ho CT; Li S
Compr Rev Food Sci Food Saf; 2021 Jan; 20(1):225-251. PubMed ID: 33443802
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement.
Patrone V; Puglisi E; Cardinali M; Schnitzler TS; Svegliati S; Festa A; Gabrielli A; Morelli L
Sci Rep; 2017 Nov; 7(1):14874. PubMed ID: 29093509
[TBL] [Abstract][Full Text] [Related]
5. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease.
Collins SM; Bercik P
Gastroenterology; 2009 May; 136(6):2003-14. PubMed ID: 19457424
[TBL] [Abstract][Full Text] [Related]
6. The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids.
Cassidy A; Minihane AM
Am J Clin Nutr; 2017 Jan; 105(1):10-22. PubMed ID: 27881391
[TBL] [Abstract][Full Text] [Related]
7. Association between oxidative status and the composition of intestinal microbiota along the gastrointestinal tract.
Gyuraszova M; Kovalcikova A; Gardlik R
Med Hypotheses; 2017 Jun; 103():81-85. PubMed ID: 28571818
[TBL] [Abstract][Full Text] [Related]
8. Interplay Between Gut Microbiota and Gastrointestinal Peptides: Potential Outcomes on the Regulation of Glucose Control.
Lupien-Meilleur J; Andrich DE; Quinn S; Micaelli-Baret C; St-Amand R; Roy D; St-Pierre DH
Can J Diabetes; 2020 Jun; 44(4):359-367. PubMed ID: 32057671
[TBL] [Abstract][Full Text] [Related]
9. Intestinal Permeability, Inflammation and the Role of Nutrients.
Farré R; Fiorani M; Abdu Rahiman S; Matteoli G
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32340206
[TBL] [Abstract][Full Text] [Related]
10. Associations between Flavonoid Intakes and Gut Microbiota in a Group of Adults with Cystic Fibrosis.
Li L; Somerset S
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30205496
[TBL] [Abstract][Full Text] [Related]
11. Prebiotic effects: metabolic and health benefits.
Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
[TBL] [Abstract][Full Text] [Related]
12. Flavonoids and gut health.
Pei R; Liu X; Bolling B
Curr Opin Biotechnol; 2020 Feb; 61():153-159. PubMed ID: 31954357
[TBL] [Abstract][Full Text] [Related]
13. Involvement of gut microbiota in association between GLP-1/GLP-1 receptor expression and gastrointestinal motility.
Yang M; Fukui H; Eda H; Xu X; Kitayama Y; Hara K; Kodani M; Tomita T; Oshima T; Watari J; Miwa H
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G367-G373. PubMed ID: 28154011
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the Gastrointestinal Microbiome with Nondigestible Fermentable Carbohydrates To Improve Human Health.
Deehan EC; Duar RM; Armet AM; Perez-Muñoz ME; Jin M; Walter J
Microbiol Spectr; 2017 Sep; 5(5):. PubMed ID: 28936943
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs.
Bjarnason I; Scarpignato C; Holmgren E; Olszewski M; Rainsford KD; Lanas A
Gastroenterology; 2018 Feb; 154(3):500-514. PubMed ID: 29221664
[TBL] [Abstract][Full Text] [Related]
16. Using bioreactors to study the effects of drugs on the human microbiota.
Guzman-Rodriguez M; McDonald JAK; Hyde R; Allen-Vercoe E; Claud EC; Sheth PM; Petrof EO
Methods; 2018 Oct; 149():31-41. PubMed ID: 30102990
[TBL] [Abstract][Full Text] [Related]
17. Alterations of gut barrier and gut microbiota in food restriction, food deprivation and protein-energy wasting.
Genton L; Cani PD; Schrenzel J
Clin Nutr; 2015 Jun; 34(3):341-9. PubMed ID: 25459400
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors.
Lopetuso LR; Scaldaferri F; Bruno G; Petito V; Franceschi F; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2015; 19(6):1068-76. PubMed ID: 25855934
[TBL] [Abstract][Full Text] [Related]
19. Flavonoid metabolism: the interaction of metabolites and gut microbiota.
Murota K; Nakamura Y; Uehara M
Biosci Biotechnol Biochem; 2018 Apr; 82(4):600-610. PubMed ID: 29504827
[TBL] [Abstract][Full Text] [Related]
20. Microbiota-Gut-Brain Axis: Modulator of Host Metabolism and Appetite.
van de Wouw M; Schellekens H; Dinan TG; Cryan JF
J Nutr; 2017 May; 147(5):727-745. PubMed ID: 28356427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
